Acute myeloid leukemia maturation lineage influences residual disease and relapse following differentiation therapy
Differentiation therapy induces the maturation and clearance of acute myeloid leukemia cells. Here, using a mouse model, the authors show that a specific lineage of mature leukemia-derived cells persists during remission and is responsible for disease relapse.
Guardado en:
Autores principales: | Steven Ngo, Ethan P. Oxley, Margherita Ghisi, Maximilian M. Garwood, Mark D. McKenzie, Helen L. Mitchell, Peter Kanellakis, Olivia Susanto, Michael J. Hickey, Andrew C. Perkins, Benjamin T. Kile, Ross A. Dickins |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f04ec10aa484e7aa4589412ec95bdf7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Centrality of Myeloid-Lineage Phagocytes in Particle-Triggered Inflammation and Autoimmunity
por: Olivia K. Favor, et al.
Publicado: (2021) -
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Theodore P. Braun, et al.
Publicado: (2019) -
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
por: Clément Larrue, et al.
Publicado: (2021) -
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection
por: Francisco Caiado, et al.
Publicado: (2019) -
Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey
por: Ayşe Hilal Eroğlu Küçükdiler, et al.
Publicado: (2021)